doi: 10.1080/10543406.2010.514456.
FDA draft guidance on adaptive design clinical trials: Pfizer's perspective
Affiliations
- PMID: 21058110
- DOI: 10.1080/10543406.2010.514456
Item in Clipboard
FDA draft guidance on adaptive design clinical trials: Pfizer's perspective
J Biopharm Stat.
2010 Nov.
Abstract
The Food and Drug Administration of the United States issued a draft guidance on adaptive design clinical trials in February 2010. This draft guidance has attracted a lot of attention because of the increasing interest in adaptive trials by the pharmaceutical industry in recent years. In this paper, we report on highlights of comments collected within Pfizer on this draft guidance. In addition, we share Pfizer's internal journey to promote efficient trial designs since 2005. Adaptive designs have been part of that journey.
Similar articles
-
Comments on the FDA draft guidance on adaptive designs.J Biopharm Stat. 2010 Nov;20(6):1166-70. doi: 10.1080/10543406.2010.514458. J Biopharm Stat. 2010. PMID: 21058112 No abstract available.
-
On flexibility of adaptive designs and criteria for choosing a good one--a discussion of FDA draft guidance.J Biopharm Stat. 2010 Nov;20(6):1171-7. doi: 10.1080/10543406.2010.514460. J Biopharm Stat. 2010. PMID: 21058113
-
Viewpoints on the FDA draft adaptive designs guidance from the PhRMA working group.J Biopharm Stat. 2010 Nov;20(6):1115-24. doi: 10.1080/10543406.2010.514452. J Biopharm Stat. 2010. PMID: 21058107
-
Review of draft FDA adaptive design guidance.J Biopharm Stat. 2010 Nov;20(6):1132-42. doi: 10.1080/10543406.2010.514455. J Biopharm Stat. 2010. PMID: 21058109 Review.
-
Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.Eur J Cancer. 2009 Feb;45(3):347-53. doi: 10.1016/j.ejca.2008.09.032. Epub 2008 Nov 14. Eur J Cancer. 2009. PMID: 19013787 Review.
Cited by
-
Adaptive design of confirmatory trials: Advances and challenges.Contemp Clin Trials. 2015 Nov;45(Pt A):93-102. doi: 10.1016/j.cct.2015.06.007. Epub 2015 Jun 14. Contemp Clin Trials. 2015. PMID: 26079372 Free PMC article.
-
An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review.PLoS One. 2015 Nov 3;10(11):e0141104. doi: 10.1371/journal.pone.0141104. eCollection 2015. PLoS One. 2015. PMID: 26528812 Free PMC article.
-
Pooled solifenacin overactive bladder trial data: Creation, validation and analysis of an integrated database.Contemp Clin Trials Commun. 2016 Oct 15;4:199-207. doi: 10.1016/j.conctc.2016.10.003. eCollection 2016 Dec 15. Contemp Clin Trials Commun. 2016. PMID: 29736483 Free PMC article.
-
Adaptive designs undertaken in clinical research: a review of registered clinical trials.Trials. 2016 Mar 19;17(1):150. doi: 10.1186/s13063-016-1273-9. Trials. 2016. PMID: 26993469 Free PMC article. Review.
-
Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.BMC Med. 2018 Nov 16;16(1):210. doi: 10.1186/s12916-018-1196-2. BMC Med. 2018. PMID: 30442137 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical